|
ZNF117 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.361700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.441800E-01 |
| Normal-vs-Stage2 |
2.721400E-01 |
| Normal-vs-Stage3 |
9.388300E-02 |
| Normal-vs-Stage4 |
4.023800E-03 |
| Stage1-vs-Stage2 |
5.515000E-01 |
| Stage1-vs-Stage3 |
2.416800E-01 |
| Stage1-vs-Stage4 |
1.250050E-02 |
| Stage2-vs-Stage3 |
7.859800E-01 |
| Stage2-vs-Stage4 |
1.060380E-01 |
| Stage3-vs-Stage4 |
1.196800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.569560E-02 |
| Normal-vs-AfricanAmerican |
4.475000E-01 |
| Normal-vs-Asian |
2.923200E-01 |
| Caucasian-vs-AfricanAmerican |
1.078440E-02 |
| Caucasian-vs-Asian |
3.924000E-01 |
| AfricanAmerican-vs-Asian |
2.285600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.061600E-02 |
| Normal-vs-Female |
2.623600E-01 |
| Male-vs-Female |
2.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.172800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.282100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.245200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.752800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.207600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.826000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.557000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.507800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.113000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.812600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.588400E-01 |
| Normal-vs-Grade 2 |
1.701640E-01 |
| Normal-vs-Grade 3 |
3.276300E-02 |
| Normal-vs-Grade 4 |
1.186620E-01 |
| Grade 1-vs-Grade 2 |
8.340200E-01 |
| Grade 1-vs-Grade 3 |
9.013400E-01 |
| Grade 1-vs-Grade 4 |
8.379000E-01 |
| Grade 2-vs-Grade 3 |
3.540600E-01 |
| Grade 2-vs-Grade 4 |
4.256800E-01 |
| Grade 3-vs-Grade 4 |
8.146000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.077650E-01 |
| Normal-vs-ccB subtype |
2.015000E-01 |
| ccA subtype-vs-ccB subtype |
9.579000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.000100E-02 |
| Normal-vs-N1 |
4.198600E-01 |
| N0-vs-N1 |
9.134400E-01 |
|
|
